Iowa City, IA, United States of America

Ravinder Reddy Gaddam

This inventor holds 1 USPTO granted patent. Top assignee: University of Connecticut. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ravinder Reddy Gaddam. Retrieved from https://idiyas.com/inventor/ravinder-reddy-gaddam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ravinder Reddy Gaddam

Introduction

Ravinder Reddy Gaddam is an accomplished inventor based in Iowa City, IA. He has made significant contributions to the field of therapeutic nucleic acid-based molecules. His work is particularly focused on the development of innovative methods and compositions that utilize gamma peptide nucleic acids.

Latest Patents

Ravinder Reddy Gaddam holds a patent for "Methods and Compositions Comprising Therapeutic Gamma Peptide Nucleic Acid-Based Molecules." This patent represents a notable advancement in therapeutic applications, showcasing his expertise and dedication to innovation.

Career Highlights

Gaddam is affiliated with the University of Connecticut, where he continues to engage in groundbreaking research. His work at the university has allowed him to explore various aspects of therapeutic technologies, contributing to the advancement of medical science.

Collaborations

Throughout his career, Gaddam has collaborated with esteemed colleagues such as Ajit Vikram and Kaikobad Irani. These partnerships have fostered a collaborative environment that enhances the potential for innovative discoveries.

Conclusion

Ravinder Reddy Gaddam is a prominent figure in the field of therapeutic innovations, with a focus on nucleic acid-based technologies. His contributions through patents and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…